Published in BMC Nephrol on January 15, 2014
Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis (2016) 0.81
An education initiative modifies opinions of hemodialysis nurses towards home dialysis. Can J Kidney Health Dis (2015) 0.79
Patients' and carers' experiences of interacting with home haemodialysis technology: implications for quality and safety. BMC Nephrol (2014) 0.76
Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study. PLoS One (2015) 0.76
Multidisciplinary staff attitudes to home haemodialysis therapy. Clin Kidney J (2017) 0.75
The global pediatric nephrology workforce: a survey of the International Pediatric Nephrology Association. BMC Nephrol (2016) 0.75
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31
Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med (2011) 4.62
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med (2010) 3.78
Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant (2010) 2.67
Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int (2008) 2.56
Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int (2011) 2.35
Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol (2012) 2.15
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol (2012) 2.03
Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Am J Kidney Dis (2011) 1.92
Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int (2002) 1.88
Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int (2009) 1.87
Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int (2003) 1.87
Patient-perceived barriers to the adoption of nocturnal home hemodialysis. Clin J Am Soc Nephrol (2009) 1.68
Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol (2006) 1.58
Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis (2010) 1.53
Patient quality of life on quotidian hemodialysis. Am J Kidney Dis (2003) 1.51
Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 1.42
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
Has the incidence of end-stage renal disease in the USA and other countries stabilized? Curr Opin Nephrol Hypertens (2011) 1.20
The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial. Hemodial Int (2009) 1.17
How to overcome barriers and establish a successful home HD program. Clin J Am Soc Nephrol (2012) 1.14
An economic assessment model for in-center, conventional home, and more frequent home hemodialysis. Kidney Int (2011) 1.08
Public health consequences of chronic kidney disease. Clin Pharmacol Ther (2009) 1.07
How Australian nephrologists view home dialysis: results of a national survey. Nephrology (Carlton) (2011) 1.02
Temporal trends in health-related quality of life among hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 0.94
Impact of increasing haemodialysis frequency versus haemodialysis duration on removal of urea and guanidino compounds: a kinetic analysis. Nephrol Dial Transplant (2009) 0.90
Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis. Am J Kidney Dis (2012) 0.88
Patient perceptions of remote monitoring for nocturnal home hemodialysis. Hemodial Int (2010) 0.87
Patient experiences and preferences on short daily and nocturnal home hemodialysis. Hemodial Int (2012) 0.87
Phosphorus dynamics during hemodialysis. Hemodial Int (2011) 0.85
International variations and trends in home hemodialysis. Adv Chronic Kidney Dis (2009) 0.85
What happened in Finland to increase home hemodialysis? Hemodial Int (2008) 0.84
Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes? Clin J Am Soc Nephrol (2009) 0.83
International practice patterns and factors associated with non-conventional hemodialysis utilization. BMC Nephrol (2011) 0.82
Home hemodialysis in Australia and New Zealand: how and why it has been successful. Semin Dial (2011) 0.82
Systematic differences among patients initiated on home haemodialysis and peritoneal dialysis: the fallacy of potential competition. Nephrol Dial Transplant (2010) 0.82
Survival comparisons between haemodialysis and peritoneal dialysis. Nephrol Dial Transplant (2012) 0.80
Nightly home hemodialysis: outcome and factors associated with survival. Hemodial Int (2011) 0.80
Resurgence in home haemodialysis: perspectives from the UK. NDT Plus (2011) 0.77
Can intensive hemodialysis prevent loss of functionality in the elderly ESRD patient? Semin Dial (2011) 0.77
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
EBPG on Vascular Access. Nephrol Dial Transplant (2007) 3.26
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol (2007) 2.18
Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol (2012) 2.15
A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant (2012) 1.94
Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol (2013) 1.93
EBPG guideline on dialysis strategies. Nephrol Dial Transplant (2007) 1.90
Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant (2010) 1.90
Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int (2009) 1.87
Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant (2002) 1.81
Physical activity and energy expenditure in haemodialysis patients: an international survey. Nephrol Dial Transplant (2011) 1.74
Acute renal infarction: a case series. Clin J Am Soc Nephrol (2012) 1.68
EBPG guideline on haemodynamic instability. Nephrol Dial Transplant (2007) 1.65
Recruitment and training for home hemodialysis: experience and lessons from the Nocturnal Dialysis Trial. Clin J Am Soc Nephrol (2010) 1.64
Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial (2005) 1.58
European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant (2013) 1.40
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int (2013) 1.31
Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis (2005) 1.17
Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res (2010) 1.16
Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis (2005) 1.15
Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant (2004) 1.15
Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study. Nephrol Dial Transplant (2009) 1.14
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant (2010) 1.11
Serum creatinine improves body mass index survival prediction in hemodialysis patients: a 1-year prospective cohort analysis from the ARNOS study. J Ren Nutr (2011) 1.09
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant (2002) 1.05
p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol (2013) 1.04
The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J Am Soc Nephrol (2002) 1.02
Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. Kidney Int (2002) 1.02
Chronic dehydration may impair renal function in patients with chronic intestinal failure on long-term parenteral nutrition. Clin Nutr (2005) 0.96
Keto acid therapy in predialysis chronic kidney disease patients: final consensus. J Ren Nutr (2012) 0.95
Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients? Semin Dial (2013) 0.94
Impact of serum albumin and body-mass index on survival in hemodialysis patients. Int Urol Nephrol (2007) 0.93
Influence of inflammation on total energy expenditure in hemodialysis patients. J Ren Nutr (2011) 0.92
Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: a systematic review. Nephrol Dial Transplant (2010) 0.91
Long-term outcome on renal replacement therapy in patients who previously received a keto acid-supplemented very-low-protein diet. Am J Clin Nutr (2009) 0.90
Protein-restricted diets plus keto/amino acids--a valid therapeutic approach for chronic kidney disease patients. J Ren Nutr (2012) 0.90
Bone imaging and chronic kidney disease: will high-resolution peripheral tomography improve bone evaluation and therapeutic management? J Ren Nutr (2009) 0.90
A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant (2013) 0.89
Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie (2013) 0.89
Mineral and bone disease pattern in elderly haemodialysis patients. Nephrol Dial Transplant (2010) 0.89
The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol Dial Transplant (2009) 0.89
Zinc deficiency in chronic kidney disease: is there a relationship with adipose tissue and atherosclerosis? Biol Trace Elem Res (2009) 0.87
Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease. Future Microbiol (2014) 0.87
Handgrip strength and its dialysis determinants in hemodialysis patients. Nutrition (2011) 0.86
European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant (2008) 0.86
White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease. Kidney Int (2013) 0.86
Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction. Clin Kidney J (2013) 0.86
Protein-bound uremic toxins…new targets to prevent insulin resistance and dysmetabolism in patients with chronic kidney disease. J Ren Nutr (2013) 0.86
Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients. Nephrol Dial Transplant (2009) 0.86
Bone microarchitecture is more severely affected in patients on hemodialysis than in those receiving peritoneal dialysis. Kidney Int (2012) 0.85
Application of branched-chain amino acids in human pathological states: renal failure. J Nutr (2006) 0.84
Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases. J Ren Nutr (2013) 0.84
Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients. Future Microbiol (2013) 0.84
Zinc-α2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients? Ren Fail (2012) 0.83
Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients. J Ren Nutr (2004) 0.82
Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients. Nutrition (2013) 0.82
Human uremic plasma and not urea induces exuberant secretion of leptin in 3T3-L1 adipocytes. J Ren Nutr (2011) 0.81
Renal perfusion: noninvasive measurement with multidetector CT versus fluorescent microspheres in a pig model. Radiology (2011) 0.81
Are ghrelin and leptin involved in food intake and body mass index in maintenance hemodialysis? J Ren Nutr (2009) 0.81
Leptin, adiponectin, and ghrelin dysregulation in chronic kidney disease. J Ren Nutr (2005) 0.80
[European recommendations for good practice in hemodialysis. Part two]. Nephrol Ther (2008) 0.80
[Evolution of the diet from the paleolithic to today: progress or regress?]. Nephrol Ther (2013) 0.80
What guidelines should or should not be: implications for guideline production. Nephrol Dial Transplant (2013) 0.80
Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study. Nephrol Dial Transplant (2010) 0.80
Short-term administration of a combination of recombinant growth hormone and insulin-like growth factor-I induces anabolism in maintenance hemodialysis. J Clin Endocrinol Metab (2009) 0.79
Calcium carbonate, but not sevelamer, is associated with better outcomes in hemodialysis patients: results from the French ARNOS study. Hemodial Int (2011) 0.79
Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients? Future Microbiol (2015) 0.78
Keto-acid therapy in predialysis chronic kidney disease patients: consensus statements. J Ren Nutr (2009) 0.78
[Direct medical cost of erythropoiesis-stimulating agents in anaemia treatment of chronic renal failure patient: a literature review]. Nephrol Ther (2010) 0.78
[Higher dialysate calcium is not associated with mortality in hemodialysis patients: results from the French ARNOS study]. Nephrol Ther (2012) 0.78
Nutritional advantages of nightly home hemodialysis. Nephrol News Issues (2002) 0.78
Mineral and bone metabolism in dialysis: towards unified patient care? Nephrol Dial Transplant (2010) 0.77
Effect of a very low-protein diet on long-term outcomes. Am J Kidney Dis (2009) 0.77
Adiponectin and chronic kidney disease. J Ren Nutr (2007) 0.77
[Choosing between peritoneal dialysis and haemodialysis: a critical appraisal of the literature]. Nephrol Ther (2005) 0.77
Why is the diet intervention so critical during chronic kidney disease? J Ren Nutr (2003) 0.77
[Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study]. Nephrol Ther (2011) 0.77
Is a body mass index of 23 kg/m² a reliable marker of protein-energy wasting in hemodialysis patients? Nutrition (2012) 0.77
[Insulin resistance and inflammation in chronic kidney diseases]. Nephrol Ther (2009) 0.77
Underreporting of energy intake in maintenance hemodialysis patients: a cross-sectional study. J Ren Nutr (2012) 0.77
Growth hormone induces anabolism in malnourished maintenance haemodialysis patients. Nephrol Dial Transplant (2005) 0.76
Dynamic renal blood flow measurement by positron emission tomography in patients with CRF. Am J Kidney Dis (2002) 0.76
[Mineral and bone status in French maintenance hemodialysis patients: a comparison of June 2005 and June 2008]. Nephrol Ther (2009) 0.76
Assessment of bone microarchitecture in chronic kidney disease: a comparison of 2D bone texture analysis and high-resolution peripheral quantitative computed tomography at the radius and tibia. Calcif Tissue Int (2010) 0.76
Dietary phosphate assessment in dialysis patients. J Ren Nutr (2010) 0.75
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2). Nephrol Dial Transplant (2016) 0.75
To supplement or not: that is the question. Clin J Am Soc Nephrol (2013) 0.75
Phosphate intake and the CARE study. Kidney Int (2004) 0.75
Good evidence evaluation for good risk assessment. Arch Intern Med (2007) 0.75
Comparison of a Bayesian network with a logistic regression model to forecast IgA nephropathy. Biomed Res Int (2013) 0.75
The ubiquitous nature and elusive role of phosphorus and vascular calcification. Am J Kidney Dis (2009) 0.75
Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure. J Nephrol (2002) 0.75
How is body mass index protective in maintenance dialysis? J Ren Nutr (2008) 0.75
Protein intake in chronic renal failure revisited. G Ital Nefrol (2014) 0.75
Resistance training in hemodialysis patients: a review. Rehabil Nurs (2014) 0.75
[Parathormone and chronic kidney disease]. Nephrol Ther (2007) 0.75
Management of hyperphosphataemia: practices and perspectives amongst the renal care community. J Ren Care (2014) 0.75
[Bone imaging in patient with chronic kidney disease: a new tool for managing renal osteodystrophy?]. Nephrol Ther (2008) 0.75